MedPath

Chest dRain rEmoval intrAoperatively afTer thoracOscopic Wedge Resection

Not Applicable
Completed
Conditions
Pain
Opioid Use
Lung Surgery
Fast-track Surgery
Enhanced Recovery After Surgery
Lung Neoplasms
Remission
Registration Number
NCT05358158
Lead Sponsor
Rigshospitalet, Denmark
Brief Summary

Chest drain is used routinely after lung surgery. Despite preliminary studies demonstrate the feasibility and safety of intraoperative chest drain removal, these are either retrospective or mainly concerning benign disease.

Hypothesis: Participants treated without post-operative chest tube after thoracoscopic wedge resection have less pain, reduced opioid usage without increasing postoperative complications than participants treated with standard post-operative chest tube, and could possibly be discharged earlier.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
94
Inclusion Criteria
  • Age ≥18 years.
  • Patients referred for elective three port video-assisted thoracoscopic surgery wedge resection of the lung for suspected or confirmed malignant nodules.
  • first second forced expiratory volume ≥60% of expected.
  • No increased bleeding risk (e.g. preoperative international normalized ratio >2, overdue discontinuation of anticoagulants according to guidelines by the Danish Society for Thrombosis and Haemostasis, known coagulopathy).
  • Not scheduled for frozen section pathology of wedge resection and subsequent lobectomy.
  • Able and willing to give informed consent.
Exclusion Criteria
  • Increased risk of post-operative air leak assessed perioperatively by the surgeon (e.g. severe adhesions, bullous/emphysematous lung tissue, defects of the visceral pleura due to iatrogenic or other reasons, suturing in the lung tissue, deep lung resection).
  • Increased risk of post-operative bleeding assessed perioperatively by the surgeon (e.g. intraoperative bleeding or oozing).
  • Air leak during intraoperative air leak test.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Acute PainUp to postoperative day 1

Postoperative pain assessed in three different situations (at rest, arms lifted and during cough) by questionnaire at 3 and 6 hours after surgery, and on the morning of postoperative day 1 at 8 a.m

Rescue analgesicsUp to postoperative day 1

The amount of rescue analgesics given assessed as cumulative amount of morphine during the first 24 hours after surgery milligram equivalents (MME) as defined by pro.medicine.dk hosted by the Danish Association of the Pharmaceutical Industry

Secondary Outcome Measures
NameTimeMethod
Time to fulfilled discharge criteriaThrough post-operative discharge, an average of 2 days

Days to meet discharge criteria but stay in hospital

PneumothoraxUp to postoperative 2 weeks

Number and size of pneumothorax at 6 hours after surgery in the drain-free group, 2 hours after drain removal in the drain group, and postoperative 2-week for both

ComplicationsUp to postoperative day 30

Surgical and medical complications including mortality

Quality of recovery after surgeryUp to postoperative day 1

Evaluate patients' quality of life by questionnaire before surgery, at the first day after surgery

Standard analgesics givenUp to postoperative 2 weeks

Number of patients who did not receive planned postoperative analgesics according to the standards at their institution

Persistent painUp to postoperative day 6

Postoperative pain assessed in three different situations (at rest, arms lifted and during cough) by questionnaire from postoperative day 2 to 6.

Length of stayThrough post-operative discharge, an average of 2 days

Days in hospital after index surgery

ReadmissionThrough post-operative admission, an average of 7 days

Number and reasons of readmissions

Chest drain reinsertionUp to postoperative day 30

Number and reasons of chest drain reinsertion

Trial Locations

Locations (2)

Thomas Decker Christensen

🇩🇰

Aarhus, Aarhus N, Denmark

Rigshospitalet

🇩🇰

Copenhagen, Denmark

Thomas Decker Christensen
🇩🇰Aarhus, Aarhus N, Denmark

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.